Literature DB >> 10867252

In vitro evaluation of sol-gel processed spray dried silica gel microspheres as carrier in controlled drug delivery.

P Kortesuo1, M Ahola, M Kangas, I Kangasniemi, A Yli-Urpo, J Kiesvaara.   

Abstract

The objective of this study was to evaluate sol-gel-derived spray dried silica gel microspheres as carrier material for dexmedetomidine HCl and toremifene citrate. The drug was dissolved in sol-gel processed silica sol before spray drying with Büchi laboratory scale equipment. Microspheres with a low specific surface area were spherical by shape with a smooth surface without pores on the external surface. The particle size distribution was quite narrow. The in vitro release of toremifene citrate and dexmedetomidine HCl showed a dose-dependent burst followed by a slower release phase, that was proportional to the drug concentration in the concentration range between 3.9 and 15.4 wt.%. The release period for toremifene citrate was approximately 10 days and for dexmedetomidine HCl between 7 and 50 days depending on drug concentration. Spray drying is a promising way to produce spherical silica gel particles with a narrow particle size range for controlled delivery of toremifene citrate and dexmedetomidine HCl.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10867252     DOI: 10.1016/s0378-5173(00)00393-8

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  11 in total

Review 1.  Pharmaceutical particle engineering via spray drying.

Authors:  Reinhard Vehring
Journal:  Pharm Res       Date:  2007-11-28       Impact factor: 4.200

2.  Controlled release of small molecules from silica xerogel with limited nanoporosity.

Authors:  Rong Chen; Haibo Qu; Ashwin Agrawal; Shaoyun Guo; Paul Ducheyne
Journal:  J Mater Sci Mater Med       Date:  2012-10-10       Impact factor: 3.896

3.  Silica microparticles for sustained zero-order release of an anti-CD40L antibody.

Authors:  Puneet Tyagi; Mika Koskinen; Jari Mikkola; Lasse Leino; Alexander Schwarz
Journal:  Drug Deliv Transl Res       Date:  2018-04       Impact factor: 4.617

4.  Nanocapsules: the weapons for novel drug delivery systems.

Authors:  Pavankumar Kothamasu; Hemanth Kanumur; Niranjan Ravur; Chiranjeevi Maddu; Radhika Parasuramrajam; Sivakumar Thangavel
Journal:  Bioimpacts       Date:  2012-04-05

5.  Preparation and In-vitro Evaluation of Rifampin-loaded Mesoporous Silica Nanoaggregates by an Experimental Design.

Authors:  Meysam Mohseni; Kambiz Gilani; Zohreh Bahrami; Noushin Bolourchian; Seyed Alireza Mortazavi
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

6.  Preparation and characterization of rifampin loaded mesoporous silica nanoparticles as a potential system for pulmonary drug delivery.

Authors:  Meysam Mohseni; Kambiz Gilani; Seyed Alireza Mortazavi
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

7.  Silica-Gentamicin Nanohybrids: Synthesis and Antimicrobial Action.

Authors:  Dina Ahmed Mosselhy; Yanling Ge; Michael Gasik; Katrina Nordström; Olli Natri; Simo-Pekka Hannula
Journal:  Materials (Basel)       Date:  2016-03-05       Impact factor: 3.623

8.  Anticorrosion and Cytocompatibility Assessment of Graphene-Doped Hybrid Silica and Plasma Electrolytic Oxidation Coatings for Biomedical Applications.

Authors:  Juan P Fernández-Hernán; Antonio J López; Belén Torres; Enrique Martínez-Campos; Endzhe Matykina; Joaquín Rams
Journal:  ACS Biomater Sci Eng       Date:  2021-11-08

Review 9.  Chronology of Global Success: 20 Years of Prof Vallet-Regí Solving Questions.

Authors:  Miguel Manzano
Journal:  Pharmaceutics       Date:  2021-12-17       Impact factor: 6.321

10.  Injectable Biodegradable Silica Depot: Two Months of Sustained Release of the Blood Glucose Lowering Peptide, Pramlintide.

Authors:  Puneet Tyagi; Mika Koskinen; Jari Mikkola; Sanjay Sarkhel; Lasse Leino; Asha Seth; Shimona Madalli; Sarah Will; Victor G Howard; Helen Brant; Dominic Corkill
Journal:  Pharmaceutics       Date:  2022-03-02       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.